Skip to search formSkip to main contentSkip to account menu

Hematopoietic Stem Cell Mobilization

Known as: Mobilization, Stem Cell, Stem Cell Mobilization, stem cell mobilisation 
The release of stem cells from the bone marrow into the peripheral blood circulation for the purpose of leukapheresis, prior to stem cell… 
National Institutes of Health

Related topics

Related topics

4 relations
Apheresis (procedure)Hemopoietic stem cell transplantnursing therapystandards characteristics

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Advances in stem cell mobilization.
Highly Cited
2011
Highly Cited
2011
First experience of autologous peripheral blood stem cell mobilization with biosimilar granulocyte colony- stimulating factor
IntroductionMobilization techniques for autologous peripheral blood stem cell (PBSC) collection include chemotherapy followed by… 
Highly Cited
2008
Highly Cited
2008
New mutations of MPL in primitive myelofibrosis: only the MPL W515 mutations promote a G1/S-phase transition
MPL (or thrombopoietin receptor, TPO-R) 515 mutations have recently been described in 5–10% of primitive myelofibrosis (PMF… 
2006
2006
Effects of peripheral blood stem cell mobilization with granulocyte-colony stimulating factor and their transcoronary transplantation after primary stent implantation for acute myocardial infarction.
2006
2006
Pre-mobilization therapy blood CD34+ cell count predicts the likelihood of successful hematopoietic stem cell mobilization
We examined pre-mobilization blood CD34+ cell count to predict ability to mobilize adequate peripheral blood progenitor cells… 
Review
2000
Review
2000
Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): a report of the European Blood and Marrow Transplantation (EBMT…
We performed a survey from 122 centres of the European Group of Blood and Marrow Transplantation (EBMT) concerning peripheral… 
Highly Cited
1999
Highly Cited
1999
Endogenous interleukin-8 (IL-8) surge in granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization.
The relationship between stem cell mobilization with granulocyte colony-stimulating factor (G-CSF) and the endogenous production… 
Highly Cited
1999
Highly Cited
1999
Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma.
The chimeric anti-CD20 monoclonal antibody rituximab (Rituxan; IDEC Pharmaceuticals, San Diego, CA, and Genentech, Inc, San… 
Highly Cited
1999
Highly Cited
1999
Superior autologous blood stem cell mobilization from dose-intensive cyclophosphamide, etoposide, cisplatin plus G-CSF than from less intensive chemotherapy regimens
The study purpose was to determine if G-CSF plus dose-intensive cyclophosphamide 5.25 g/m2, etoposide 1.05 g/m2 and cisplatin 105… 
Highly Cited
1999
Highly Cited
1999
Recurrent mutations in the iron regulatory element of L-ferritin in hereditary hyperferritinemia-cataract syndrome.
BACKGROUND AND OBJECTIVE Hereditary hyperferritinemia-cataract syndrome (HHCS) is an autosomal dominant disorder characterized by… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)